Markets /Healthcare /CLVS Clovis Oncology, Inc. CLVS Full chart Compare Add to watchlist Set alert Price alert · CLVS Alert when the price is Price abovePrice below Price level Set alert All alert types 0.08 +0.08 Day range unavailable 52-week range unavailable Overview Chart Financials FinancialsValuation & healthEarnings EarningsDividends & splitsAnalysts News Ownership Options More ComparisonSignalsTrend ScoreDiscussionNotesPositionsAlerts FinancialsValuation & health OverviewIncome statementBalance sheetCash flow Revenue & Expenses AnnualQuarterly Revenue by Segment FY 2021FY 2020FY 2019FY 2018 Income Tax Benefit → Expenses: $404.00KU.S. → Revenue: $115.67MExpenses → Selling, General & Admin: $128.40MExpenses → Research & Development: $192.08MExpenses → Other Operating Expenses: $15.22MExpenses → Interest Expense: $31.67MExpenses → Other Expenses: $7.49MGross Profit → Expenses: $109.93MRevenue → Gross Profit: $109.93MRevenue → Cost of Revenue: $38.83Mex U.S. → Revenue: $33.08MNet Loss → Expenses: $264.52MIncome Tax Benefit$404.00KGross Profit$109.93MNet Loss$264.52MCost of Revenue$38.83MExpenses$374.86MSelling, General & Admin$128.40MResearch & Development$192.08MOther Operating Expenses$15.22MInterest Expense$31.67MOther Expenses$7.49MRevenue$148.76MU.S.$115.67Mex U.S.$33.08M No annual statement lines CLVS has no annual lines for this statement.
